A/Prof Anneke van der Walt is an academic Neurologist with subspecialty training in multiple sclerosis and neuroimmunology as well as neuro-ophthalmology. She leads the MS and Neuro-ophthalmology Research Group at the Central Clinical School, Monash University.

A/Prof van der Walt completed her undergraduate training in South Africa before relocating to Australia where she completed specialist training in Neurology and a PhD in Neuroscience under supervision of Professors Trevor Kilpatrick and Helmut Butzkueven at the University of Melbourne. This was followed by postdoctoral training at the Melbourne Brain Centre, UoM (2013-2017 - postdoc; 2015-2017 - senior research fellow).

A/Prof van der Walt has received substantial competitive fellowship and grant funding, totalling $17,633,282 to date from NHMRC, MRFF, inetrnational funding and several industry grants. 

With a H-index of 26, her peer-reviewed published research has garnered almost 1844 citations to date.  

Van Der Walt Lab

A/Prof van der Walt's research interests include cerebellar dysfunction in MS, and MS cognition, and women's health. She leads several large national and international studies on digital biomarkers in MS.

A/Prof van der Walt is also the Chief Operating Officer of the MSBae foundation.  Her clinical roles includes appointments as the HEad, MSNI Unit and Neuro-ophthalmology Service at Alfred Health, Melbourne. 

A/Prof van der Walt has extensive experience supervising postdoctoral fellows, PhD students, Masters and Honours students. She currently overseas 5 post docs and 5 PhD students. Six PhD students, 1 Masters student and 5 Honours student have sucessfully completed research projects under A/Prof van der Walt's supervision.

2018-2020

• MS ATLAS meeting: Chair, Steering committee (Biogen)

2017-2018

• Atrophy in MS (AIMS) Initiative: Steering committee (Genzyme)
• MS innovations meeting
• Steering committee (Novartis, Genzyme)

2017

• Siponimod advisory Board, (Novartis)
• MS ATLAS meeting: Steering committee (Biogen)
• Cladribine advisory board, February (Merck)

2015

• Cladribine advisory board, (Merck)
• Advisory Board for Merck Serono

2010

• Advisory boards for Merck Serono

2009

• Advisory boards for Bayer Schering

2019

• TRM006 Translational Neuroscience Masters Degree. Seminar: Assessment of the anterior visual system and role in translation in multiple sclerosis.

2018     

• Teaching of 3rd year medical students, CCS, Monash University.

2018 - ongoing

• Multiple Sclerosis Research Australia (MSRA): Research Medical Council Grant Panels

2019-2020

• MSRA Incubator Grants: Round 1 and 2

2017- 2018

• NHMRC: external assessor, Project Grants